phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with 8-phenyltheophylline in 1 studies
| Studies (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Trials (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Recent Studies (post-2010) (phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide) | Studies (8-phenyltheophylline) | Trials (8-phenyltheophylline) | Recent Studies (post-2010) (8-phenyltheophylline) |
|---|---|---|---|---|---|
| 276 | 0 | 55 | 518 | 0 | 11 |
| Protein | Taxonomy | phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide (IC50) | 8-phenyltheophylline (IC50) |
|---|---|---|---|
| Adenosine receptor A3 | Homo sapiens (human) | 1.25 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.2756 | |
| Adenosine receptor A1 | Bos taurus (cattle) | 0.003 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.454 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.3125 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 1.1 | |
| Adenosine receptor A1 | Homo sapiens (human) | 1.34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gouardères, C; Jhamandas, K; Sutak, M; Zajac, JM | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and 8-phenyltheophylline
| Article | Year |
|---|---|
Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
Topics: Adenosine; Analgesics, Opioid; Animals; Male; Morphine; Oligopeptides; Rats; Rats, Sprague-Dawley; Spinal Cord; Theophylline | 2000 |